Ameriprise’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Ameriprise’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,507	Closed	-$243K	–	4172
2025 Q1	$243K	Buy	13,507 +474	+4%	+$8.43K	﹤0.01%	3736
2024 Q4	$228K	Sell	13,033 -17,022	-57%	-$230K	﹤0.01%	3821
2024 Q3	$346K	Sell	30,055 -67,226	-69%	-$771K	﹤0.01%	3600
2024 Q2	$1.1M	Buy	97,281 +23,457	+32%	+$312K	﹤0.01%	3127
2024 Q1	$1.06M	Buy	+73,824	New	+$1.05M	﹤0.01%	3139
2022 Q4	–	Sell	-35,794	Closed	-$312K	–	4065
2022 Q3	$312K	Buy	35,794 +716	+2%	+$7.43K	﹤0.01%	3570
2022 Q2	$349K	Buy	+35,078	New	+$353K	﹤0.01%	3519

Ameriprise's PTVE Position: Q2 2025 in Review

Ameriprise sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 13,507 shares — an estimated $243K sold.

Ameriprise first reported a position in PTVE in Q2 2022 and held it in 7 quarters. The position peaked at $1.1M in Q2 2024. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

Ameriprise reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
Ameriprise sold 13,507 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $243K.
Ameriprise first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2022 and held it in 7 quarters.
Ameriprise's Pactiv Evergreen Inc. Common stock position peaked at $1.1M in Q2 2024.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.